Clinical and economic outcomes of medication therapy management services: The Minnesota experience

Journal of the American Pharmacists Association

Volumn 48, Issue 2, 2008, Pages 203-214

  Isetts, Brian J ^a   Schondelmeyer, Stephen W ^a   Artz, Margaret B ^b   Lenarz, Lois A ^c   Heaton, Alan H ^d   Wadd, Wallace B ^e   Brown, Lawrence M ^f   Cipolle, Robert J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Ingenix Inc   (United States)

^c UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^d Blue Cross Blue Shield of Minnesota   (United States)

^e Prime Therapeutics LLC   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Chronic disease; Collaborative practice; Economics; Medication therapy management services; Pharmaceutical care

Indexed keywords

AGED; AMBULATORY CARE; ARTICLE; CHRONIC DISEASE; COOPERATION; ECONOMICS; EVALUATION; FEMALE; HEALTH CARE COST; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PHARMACIST; PHARMACY; PROFESSIONAL STANDARD; PROSPECTIVE STUDY; UNITED STATES;

AGED; AMBULATORY CARE; CHRONIC DISEASE; COMMUNITY PHARMACY SERVICES; COOPERATIVE BEHAVIOR; FEMALE; HEALTH CARE COSTS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; MINNESOTA; PHARMACISTS; PROFESSIONAL ROLE; PROSPECTIVE STUDIES;

EID: 42149166879     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2008.07108     Document Type: Article

References (46)

1. Mikeal RL, Brown TP, Lazarus HL, Vinson MC. Quality of pharmaceutical care in hospitals. Am J Hosp Pharm. 1975;32:567-74.
2. Smith WE, Benderev K. Levels of pharmaceutical care: a theoretical model. Am J Hosp Pharm. 1991;48:540-6.
3. Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med. 2003;163:1813-20.
4. Medicare Payment Advisory Commission. Report to the Congress: Medicare coverage of nonphysician practitioners. Washington, D.C.: Medicare Payment Advisory Commission; 2002:21-6.
5. Public law no. 108-173: Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Accessed at www.ustreas.gov/offices/public-affairs/ hsa/pdf/pl108-173.pdf, January 28, 2008.
6. Beebe M, Dalton, JA, Duffy C, et al. Current Procedural Terminology: CPT 2006. Chicago: American Medical Association; 2006.
7. Isetts BJ, Buffington DE. CPT code-change proposal: national data on pharmacists' medication therapy management services. J Am Pharm Assoc. 2007;47:491-5.
8. Beebe M, Dalton, JA, Duffy C, et al. Current Procedural Terminology: CPT 2008. Chicago: American Medical Association; 2008.
9. American Medical Association. CPT changes 2006: an insider's view. Chicago: American Medical Association; 2005:309-12.
10. Bluml BJ. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc. 2005;45:566-72.
11. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in Project ImPACT: Hyperlipidemia. J Am Pharm Assoc. 2000; 40:157-73.
12. Cranor CW, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149-59.
13. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002;162:1149-55.
14. Erickson SR, Slaughter MS, Halapy H. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy. 1997;17:140-7.
15. Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with dyslipidemias by independent community pharmacy practitioners. Ann Pharmacother. 1997;31:713-9.
16. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Accessed at www.cochrane.org/reviews/en/ab000336.html, April 7, 2004.
17. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267-70.
18. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163:2014-8.
19. Chiquette E, Amoato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998;158:1641-7.
20. Kaushal R, Bates DW. The clinical pharmacist's role in preventing adverse drug events. In: Shojania K, Duncan B, McDonald K, Wachter RM, eds. Making health care safer: a critical analysis of patient safety practices. Rockville, Md.: Agency for Healthcare Research and Quality; 2001 [Evidence Report/Technology Assessment no. 43; AHRQ publication 01-E058].
21. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the pharmacist in heart failure assessment recommendation and monitoring (PHARM) study. Arch Intern Med. 1999;159:1939-45.
22. Cranor CW, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173-84.
23. Schumock GT, Butler MG, Meek PD, et al. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy. 2003;23:113-32.
24. Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm. 1997;54:554-8.
25. Schumock GT, Meek PD, Ploetz, PA, Vermeulen LC. Economic evaluation of clinical pharmacy service: 1988-1995. Pharmacotherapy. 1996;16:1188-208.
26. Hatoum HT, Akhras K. 1993 bibliography: a 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists. Ann Pharmacother. 1993;27:1106-19.
27. Hatoum HT, Catizone C, Hutchinson RA, Purohit A. Eleven year review of the pharmacy literature: documentation of the value and acceptance of clinical pharmacy. Drug Intell Clin Pharm. 1986;20:33-48.
28. Hammond RW, Schwartz AH, Campbell MJ, et al. Collaborative drug therapy management by pharmacists: 2003. Pharmacotherapy. 2003;23:1210-25.
29. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996;74:511-44.
30. Von Korff M, Gruman J, Schaefer J, et al. Collaborative management of chronic illness. Ann Intern Med. 1997;19:1097-102.
31. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness. Eff Clin Pract. 1998;1:1-4.
32. Bodenheimer TS, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288:1775-9.
33. Wagner EH, Glasgow RE, Davis C, et al. Quality improvement in chronic illness care: a collaborative approach. Jt Comm J Qual Improv. 2001;27:63-80.
34. RAND Corporation. Improving chronic illness care evaluation. Accessed at www.rand.org/health/ICICE, December 7, 2007.
35. Porter ME, Teisberg EO. Redefining health care: creating value-based competition on results. Boston: Harvard Business School Press; 2006.
36. Meyer J, Rybowski L, Eichler R. Theory and reality of value-based purchasing: lessons from the pioneers. Accessed at www.ahrq.gov/qual/meyerrpt. htm, July 14, 2007.
37. Pham HH, Schrag D, O'Malley AS, et al. Care patterns in Medicare and their implications for pay for performance. N Engl J Med. 2007;356:1130-9.
38. Glickman SW, Ou F, DeLong ER, et al. Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA. 2007;297:2373-80.
39. Webber A. Building the business case for quality improvement. J Am Pharm Assoc. 2005;45:437-42.
40. Isetts BJ, Schondelmeyer SW, Heaton AH, et al. Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life. Res Social Adm Pharm. 2006;2:129-42.
41. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the clinician's guide. New York: McGraw-Hill; 2004.
42. Isetts BJ, Sorensen TD. Use of a student-driven, university-based pharmaceutical care clinic to define the highest standards of patient care. Am J Pharm Educ. 1999;63:443-9.
43. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill; 1998.
44. Brown LM. A peer-review study of the quality of care provided by pharmaceutical care practitioners in an ambulatory care clinic setting. Minneapolis: University of Minnesota; 2003 [doctoral dissertation].
45. Darling H, Isham GJ. HEDIS 2001 technical specifications. Vol. 2. Washington, D.C.: National Committee for Quality Assurance; 2000.
46. National Committee for Quality Assurance. HEDIS 2001 national averages for commercial insurance products: NCQA quality compass 2001. Accessed with permission at www.ncqa.org/communications/news/somc2001.htm by Michele Taylor, Analyst, Information Products, National Committee for Quality Assurance, November 30, 2006.